Skip to main content

Table 1 Demographic, clinical characteristics and questionnaires score

From: Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires

 

Mean ± SD or Percentage

Range

Male (%)

59 (45.4%)

 

Age, years

70.71 ± 8.50

52–90

BMI, kg/m2

26.67 ± 4.14

18.12–39.26

MMSE

19.64 ± 6.26

2–30

Mild NCD (%)

Major NCD (%)

43 (33.1%)

87 (66.9%)

 

HGS, kg

19.31 ± 7.19

5–38.70

SMI, kg/m2

9.70 ± 1.78

5–14.88

ASM, kg

20.12 ± 4.41

11.60–34.30

EWGSOP1

 Low muscle mass, (%)

35 (26.9%)

 

 Low muscle strength, (%)

93 (71.5%)

 

 Sarcopenia (%),

31 (23.8%)

 

EWGSOP2

 Low muscle mass (%)

18 (13.8%)

 

 Low muscle strength (%)

70 (53.8%)

 

 Sarcopenia (%)

6 (4.6%)

 

SARC-F-3

0.72 ± 0.89

0–4

MSRA-5

53.81 ± 4.85

40–60

  1. BMI Body Mass Index, MMSE Mini Mental State Examination, NCD Neurocognitive Disorder, HGS Hand Grip Strength, SMI Skeletal Muscle Index, ASM Appendicular Skeletal Muscle Mass, EWGSOP1 European Working Group on Sarcopenia in Older People of 2010, EWGSOP2 European Working Group on Sarcopenia in Older People of 2018, SARC-F-3 Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls questionnaire, 3-item version, MSRA-5 Mini Sarcopenia Risk Assessment questionnaire, 5-item version